GlassScriptPhysician profile
Peter Ngosong
NPI 1063839892
$940.06
in general payments reported to CMS, 2019-2025
12 companies · $44.92 in 2025
The $44.92 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $604 · 2023: $109 · 2024: $182 · 2025: $44.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $336.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $335.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $195.03 | 2022-2023 | Aristada, Lybalvi |
| Otsuka America Pharmaceutical, INC. | $183.41 | 2022-2024 | Abilify Asimtufii, Abilify Maintena, Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $109.23 | 2022 | |
| Sunovion Pharmaceuticals INC. | $79.64 | 2022 | |
| Neurocrine Biosciences, INC. | $70.69 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $68.15 | 2022-2025 | Uzedy, Austedo Xr |
| Abbvie INC. | $62.67 | 2022 | |
| Janssen Pharmaceuticals, INC | $55.70 | 2022 | |
| Uswm, LLC | $52.05 | 2022 | |
| Indivior INC. | $23.23 | 2022 | |
| Lundbeck LLC | $21.70 | 2022 | |
| Luye Pharma (USA) LTD. | $18.56 | 2025 | Erzofri Extended-Release |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Ngosong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.